Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients

Infection and Immunity

Volumn 82, Issue 11, 2014, Pages 4477-4486

  Kragh, Kasper N ^a   Alhede, Morten ^a,b   Jensen, Peter Ø ^b   Moser, Claus ^b   Scheike, Thomas ^a   Jacobsen, Carsten S ^c   Poulsen, Steen Seier ^a   Eickhardt Sørensen, Steffen Robert ^a   Trøstrup, Hannah ^b   Christoffersen, Lars ^b   Hougen, Hans Petter ^a   Rickelt, Lars F ^a   Kühl, Michael ^a,d,e   Høiby, Niels ^a,b   Bjarnsholt, Thomas ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^c GEOLOGICAL SURVEY OF DENMARK AND GREENLAND   (Denmark)

^d UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^e NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

NITRATE; PEPTIDE NUCLEIC ACID;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BIOFILM; CASE REPORT; CHEMICAL ENVIRONMENT; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG INFECTION; LUNG PARENCHYMA; LUNG TRANSPLANTATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; OXYGEN CONSUMPTION; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; RIBOSOME; SALMONELLA ENTERICA; SEROTYPE; ANIMAL; BAGG ALBINO MOUSE; IMMUNOLOGY; LUNG DISEASE; MICROBIOLOGY; PSEUDOMONAS INFECTION;

ADULT; ANIMALS; BIOFILMS; CYSTIC FIBROSIS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG DISEASES; MALE; MICE; MICE, INBRED BALB C; NEUTROPHILS; PEPTIDE NUCLEIC ACIDS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84907960445     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01969-14     Document Type: Article

References (55)

1. Koch C, Hoiby N. 2000. Diagnosis and treatment of cystic fibrosis. Respiration 67:239-247. http://dx.doi.org/10.1159/000029503.
2. Hoiby N. 2011. Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. BMC Med. 9:32. http://dx.doi.org/10.1186/1741-7015-9-32.
3. Alhede M, Bjarnsholt T, Jensen PO, Phipps RK, Moser C, Christophersen L, Christensen LD, van Gennip M, Parsek M, Hoiby N, Rasmussen TB, Givskov M. 2009. Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiology 155:3500-3508. http://dx.doi.org/10.1099/mic.0.031443-0.
4. Bjarnsholt T, Jensen PO, Fiandaca MJ, Pedersen J, Hansen CR, Andersen CB, Pressler T, Givskov M, Hoiby N. 2009. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr. Pulmonol. 44:547-558. http://dx.doi.org/10.1002/ppul.21011.
5. Høiby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen PO, Molin S, Givskov M, Tolker-Nielsen T, Bjarnsholt T. 2011. The clinical impact of bacterial biofilms. Int. J. Oral Sci. 3:55-65. http://dx.doi.org/10.4248/IJOS11026.
6. O'Toole GA. 2003. To build a biofilm. J. Bacteriol. 185:2687-2689. http://dx.doi.org/10.1128/JB.185.9.2687-2689.2003.
7. Evans DJ, Allison DG, Brown MR, Gilbert P. 1991. Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate. J. Antimicrob. Chemother. 27:177-184. http://dx.doi.org/10.1093/jac/27.2.177.
8. Borriello G, Werner E, Roe F, Kim AM, Ehrlich GD, Stewart PS. 2004. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob. Agents Chemother. 48:2659-2664. http://dx.doi.org/10.1128/AAC.48.7.2659-2664.2004.
9. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Doring G. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109:317-325. http://dx.doi.org/10.1172/JCI13870.
10. Kolpen M, Kuhl M, Bjarnsholt T, Moser C, Hansen CR, Liengaard L, Kharazmi A, Pressler T, Hoiby N, Jensen PO. 2014. Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. PLoS One 9:e84353. http://dx.doi.org/10.1371/journal.pone.0084353.
11. Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, Allen HL, DeKievit TR, Gardner PR, Schwab U, Rowe JJ, Iglewski BH, McDermott TR, Mason RP, Wozniak DJ, Hancock RE, Parsek MR, Noah TL, Boucher RC, Hassett DJ. 2002. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 3:593-603. http://dx.doi.org/10.1016/S1534-5807(02)00295-2.
12. Beckmann C, Brittnacher M, Ernst R, Mayer-Hamblett N, Miller SI, Burns JL. 2005. Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections. Infect. Immun. 73:444-452. http://dx.doi.org/10.1128/IAI.73.1.444-452.2005.
13. Son MS, Matthews WJ, Jr, Kang Y, Nguyen DT, Hoang TT. 2007. In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infect. Immun. 75:5313-5324. http://dx.doi.org/10.1128/IAI.01807-06.
14. Lee B, Schjerling CK, Kirkby N, Hoffmann N, Borup R, Molin S, Hoiby N, Ciofu O. 2011. Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients. APMIS 119:263-274. http://dx.doi.org/10.1111/j.1600-0463.2011.02726.x.
15. Kolpen M, Hansen CR, Bjarnsholt T, Moser C, Christensen LD, van Gennip M, Ciofu O, Mandsberg L, Kharazmi A, Doring G, Givskov M, Hoiby N, Jensen PO. 2010. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 65:57-62. http://dx.doi.org/10.1136/thx.2009.114512.
16. Babior BM, Curnutte JT, McMurrich BJ. 1976. The particulate superoxide-forming system from human neutrophils. Properties of the system and further evidence supporting its participation in the respiratory burst. J. Clin. Invest. 58:989-996.
17. Alvarez-Ortega C, Harwood CS. 2007. Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol. Microbiol. 65:153-165. http://dx.doi.org/10.1111/j.1365-2958.2007.05772.x.
18. Yang L, Haagensen JA, Jelsbak L, Johansen HK, Sternberg C, Hoiby N, Molin S. 2008. In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J. Bacteriol. 190:2767-2776. http://dx.doi.org/10.1128/JB.01581-07.
19. Rau MH, Hansen SK, Johansen HK, Thomsen LE, Workman CT, Nielsen KF, Jelsbak L, Hoiby N, Yang L, Molin S. 2010. Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. Environ. Microbiol. 12:1643-1658. http://dx.doi.org/10.1111/j.1462-2920.2010.02211.x.
20. Bachmann B. 1996. Derivations and genotypes of some mutant derivatives of Escherichia coli K-12, p 2460-2488. In Neidhardt FC, Curtiss R, III, Ingraham JL, Lin ECC, Low KB, Magasanik B, Reznikoff WS, Riley M, Schaechter M, Umbarger HE (ed), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. ASM Press, Washington, DC.
21. Christophersen LJ, Trostrup H, Malling Damlund DS, Bjarnsholt T, Thomsen K, Jensen PO, Hougen HP, Hoiby N, Moser C. 2012. Beadsize directed distribution of Pseudomonas aeruginosa results in distinct inflammatory response in a mouse model of chronic lung infection. Clin. Exp. Immunol. 170:222-230. http://dx.doi.org/10.1111/j.1365-2249.2012.04652.x.
22. Perry-O'Keefe H, Rigby S, Oliveira K, Sorensen D, Stender H, Coull J, Hyldig-Nielsen JJ. 2001. Identification of indicator microorganisms using a standardized PNA FISH method. J. Microbiol. Methods 47:281-292. http://dx.doi.org/10.1016/S0167-7012(01)00303-7.
23. Bjarnsholt T, Jensen PO, Burmolle M, Hentzer M, Haagensen JA, Hougen HP, Calum H, Madsen KG, Moser C, Molin S, Hoiby N, Givskov M. 2005. Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 151:373-383. http://dx.doi.org/10.1099/mic.0.27463-0.
24. Kuhl M. 2005. Optical microsensors for analysis of microbial communities. Methods Enzymol. 397:166-199. http://dx.doi.org/10.1016/S0076-6879(05)97010-9.
25. Rickelt LF, Askaer L, Walpersdorf E, Elberling B, Glud RN, Kühl M. 2013. An optode sensor array for long term in situ measurements of O2 in soil and sediment. J. Environ. Qual. 42:1267-1273. http://dx.doi.org/10.2134/jeq2012.0334.
26. Schaechter M, Maaloe O, Kjeldgaard NO. 1958. Dependency on medium and temperature of cell size and chemical composition during balanced grown of Salmonella typhimurium. J. Gen. Microbiol. 19:592-606. http://dx.doi.org/10.1099/00221287-19-3-592.
27. Baldridge CW, Gerard RW. 1932. The extra respiration of phagocytosis. Am. J. Physiol. 103:235-236.
28. West. 2000. Respiratory physiology: the essentials, 6th ed. Lippincott, Williams, and Wilkins, Baltimore, MD.
29. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. 2004. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230:13-18. http://dx.doi.org/10.1016/S0378-1097(03)00856-5.
30. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. 1995. Microbial biofilms. Annu. Rev. Microbiol. 49:711-745. http://dx.doi.org/10.1146/annurev.mi.49.100195.003431.
31. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. 2010. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents 35:322-332. http://dx.doi.org/10.1016/j.ijantimicag.2009.12.011.
32. Bjarnsholt T, Alhede M, Eickhardt-Sorensen SR, Moser C, Kuhl M, Jensen PO, Hoiby N. 2013. The in vivo biofilm. Trends Microbiol. 21:466-474. http://dx.doi.org/10.1016/j.tim.2013.06.002.
33. Wentland EJ, Stewart PS, Huang CT, McFeters GA. 1996. Spatial variations in growth rate within Klebsiella pneumoniae colonies and biofilm. Biotechnol. Prog. 12:316-321. http://dx.doi.org/10.1021/bp9600243.
34. Williamson KS, Richards LA, Perez-Osorio AC, Pitts B, McInnerney K, Stewart PS, Franklin MJ. 2012. Heterogeneity in Pseudomonas aeruginosa biofilms includes expression of ribosome hibernation factors in the antibiotic-tolerant subpopulation and hypoxia-induced stress response in the metabolically active population. J. Bacteriol. 194:2062-2073. http://dx.doi.org/10.1128/JB.00022-12.
35. Stewart PS, Franklin MJ. 2008. Physiological heterogeneity in biofilms. Nat. Rev. Microbiol. 6:199-210. http://dx.doi.org/10.1038/nrmicro1838.
36. Roberts ME, Stewart PS. 2005. Modelling protection from antimicrobial agents in biofilms through the formation of persister cells. Microbiology 151:75-80. http://dx.doi.org/10.1099/mic.0.27385-0.
37. Jesaitis AJ, Franklin MJ, Berglund D, Sasaki M, Lord CI, Bleazard JB, Duffy JE, Beyenal H, Lewandowski Z. 2003. Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J. Immunol. 171:4329-4339. http://dx.doi.org/10.4049/jimmunol.171.8.4329.
38. Zumft WG. 1997. Cell biology and molecular basis of denitrification. Microbiol. Mol. Biol. Rev. 61:533-616.
39. Palmer KL, Brown SA, Whiteley M. 2007. Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum. J. Bacteriol. 189:4449-4455. http://dx.doi.org/10.1128/JB.00162-07.
40. Francoeur C, Denis M. 1995. Nitric oxide and interleukin-8 as inflammatory components of cystic fibrosis. Inflammation 19:587-598. http://dx.doi.org/10.1007/BF01539138.
41. Hogg JC. 2004. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364:709-721. http://dx.doi.org/10.1016/S0140-6736(04)16900-6.
42. Mayer-Hamblett N, Aitken ML, Accurso FJ, Kronmal RA, Konstan MW, Burns JL, Sagel SD, Ramsey BW. 2007. Association between pulmonary function and sputum biomarkers in cystic fibrosis. Am. J. Respir. Crit. Care Med. 175:822-828. http://dx.doi.org/10.1164/rccm.200609-1354OC.
43. Jakobsen TH, Hansen MA, Jensen PO, Hansen L, Riber L, Cockburn A, Kolpen M, Ronne Hansen C, Ridderberg W, Eickhardt S, Hansen M, Kerpedjiev P, Alhede M, Qvortrup K, Burmolle M, Moser C, Kuhl M, Ciofu O, Givskov M, Sorensen SJ, Hoiby N, Bjarnsholt T. 2013. Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784 to 1996 complies with important pathogenic phenotypes. PLoS One 8:e68484. http://dx.doi.org/10.1371/journal.pone.0068484.
44. Hansen CR, Pressler T, Nielsen KG, Jensen PO, Bjarnsholt T, Hoiby N. 2010. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J. Cyst. Fibros. 9:51-58. http://dx.doi.org/10.1016/j.jcf.2009.10.005.
45. Borregaard N, Herlin T. 1982. Energy metabolism of human neutrophils during phagocytosis. J. Clin. Invest. 70:550-557. http://dx.doi.org/10.1172/JCI110647.
46. Laval J, Touhami J, Herzenberg LA, Conrad C, Taylor N, Battini JL, Sitbon M, Tirouvanziam R. 2013. Metabolic adaptation of neutrophils in cystic fibrosis airways involves distinct shifts in nutrient transporter expression. J. Immunol. 190:6043-6050. http://dx.doi.org/10.4049/jimmunol.1201755.
47. Palmer KL, Aye LM, Whiteley M. 2007. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J. Bacteriol. 189:8079-8087. http://dx.doi.org/10.1128/JB.01138-07.
48. Brennan AL, Gyi KM, Wood DM, Johnson J, Holliman R, Baines DL, Philips BJ, Geddes DM, Hodson ME, Baker EH. 2007. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J. Cyst. Fibros. 6:101-109. http://dx.doi.org/10.1016/j.jcf.2006.03.009.
49. Baker EH, Clark N, Brennan AL, Fisher DA, Gyi KM, Hodson ME, Philips BJ, Baines DL, Wood DM. 2007. Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis. J. Appl. Physiol. 102:1969-1975. http://dx.doi.org/10.1152/japplphysiol.01425.2006.
50. Vander Wauven C, Pierard A, Kley-Raymann M, Haas D. 1984. Pseudomonas aeruginosa mutants affected in anaerobic growth on arginine: evidence for a four-gene cluster encoding the arginine deiminase pathway. J. Bacteriol. 160:928-934.
51. Chen LY, Mehta JL. 1996. Variable effects of L-arginine analogs on L-arginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoforms. J. Pharmacol. Exp. Ther. 276:253-257.
52. Grasemann H, Tullis E, Ratjen F. 2013. A randomized controlled trial of inhaled L-arginine in patients with cystic fibrosis. J. Cyst. Fibros. 12:468-474. http://dx.doi.org/10.1016/j.jcf.2012.12.008.
53. Eng RH, Padberg FT, Smith SM, Tan EN, Cherubin CE. 1991. Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob. Agents Chemother. 35:1824-1828. http://dx.doi.org/10.1128/AAC.35.9.1824.
54. Carreras MC, Pargament GA, Catz SD, Poderoso JJ, Boveris A. 1994. Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils. FEBS Lett. 341:65-68. http://dx.doi.org/10.1016/0014-5793(94)80241-6.
55. Alderton WK, Cooper CE, Knowles RG. 2001. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357(Pt 3):593-615.